Objective To explore the presentation behaviours and pathways to detection of adults who first presented to UK hospital eye services with severe glaucoma. Design Semistructured interviews, based on models of diagnostic delay, to obtain a descriptive self-reported account of when and how participants' glaucoma was detected.
INTRODUCTION
Glaucoma is a condition where early detection and thus access to treatment is associated with better outcomes. [1] [2] [3] Studies have identified delays attributable to patients' late presentation for eye tests, 4 such delays being associated with risk factors such as socioeconomic deprivation, African-Caribbean ethnicity and older age. [4] [5] [6] However, little is known about the experiences of patients with severe glaucoma at diagnosis, for example, their presentation behaviours and pathways to detection. Greater understanding is essential for the development of successful interventions to optimise timely detection, diagnosis and treatment.
Existing models of 'diagnostic delay' describe decisional and behavioural processes prior to treatment. These include delay attributable to patients (eg, delay in seeking care) and diagnostic and treatment delay attributable to healthcare providers (at the individual practitioner level or at the service level). [7] [8] [9] Figure 1 illustrates the stages at which diagnostic delay of glaucoma may occur, the nature of the delay and the behaviour required (by the patient or healthcare provider) in order to access appropriate treatment.
In this qualitative study, we explored accounts of when and how glaucoma was detected in adults who first presented to hospital eye services with severe glaucoma.
METHODS

Sampling and recruitment
We sought narratives from adults who first presented to hospital eye care services (in Aberdeen or Huddersfield, UK) with glaucomatous visual field loss of −20 dB, or worse, in at least one eye, or bilateral loss of ≥−12 dB in both eyes. Consecutive patients meeting this eligibility criterion were identified from two glaucoma outpatient clinic lists (Aberdeen, Huddersfield) by clinical ophthalmologists and sent an information leaflet and a letter of invitation to participate in the study (signed by the clinician). The purposive sample was not intended to be representative or to estimate the distribution of views across the population of people presenting with late stage glaucoma. Its aim was to generate insight into the glaucoma patients' experiences and presenting behaviours.
Data collection
The study was approved by North of Scotland research ethics committee (Ref: 09/S0801/68). Semistructured face-to-face interviews were conducted, between March and November 2009, using a topic guide based on models of patient and provider delay. [7] [8] [9] [10] We obtained a descriptive account, in the participant's own words, of when and how their glaucoma was detected. In addition, we collected self-reported demographic and medical information (eg, ethnicity, family history of glaucoma) to describe our purposive sample. Formal consent was obtained. Interviews were audio-recorded, transcribed verbatim and anonymised using a unique participant identifier (P01-P11) and all other identifiable information removed (eg, ophthalmologists' names).
Data management and analysis
We used a directed content analysis approach based on existing models of diagnostic delay [7] [8] [9] to identify the behaviours and experiences that led to detection of the participants' glaucoma (detection pathways). 11 Directed content analysis involves the use of existing theory or prior research to provide initial coding categories. However, this did not preclude the emergence of new themes. One researcher (MP) worked systematically through all transcripts and created charts to summarise issues that related to participants' presentation
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RESULTS
Sample characteristics
Fourteen patients were invited to participate in the study (Aberdeen: eight; Huddersfield: six). Of these, 11 expressed an interest in taking part (Aberdeen: five; Huddersfield: six). All 11 were interviewed. No further contact was made with the other three patients. The 11 participants included seven women and four men. 
Presentation behaviours and detection pathways
Participants' accounts of when and how their glaucoma was detected were diverse. Most described the detection and subsequent diagnosis of advanced glaucoma as memorable and often distressing events, but were keen to have the opportunity to discuss and share. Four participants reported that the optometry appointment at which their glaucoma was detected was their first ever eye test or their first for over 10 years. Seven participants reported attending regular routine optometrist appointments. Their descriptions of experiences and pathways to detection included a variety of missed detection opportunities, which in some cases were combined with delays in accessing specialist ophthalmology services for treatment and monitoring. Quotes from interviews are presented below to illustrate the study findings.
Patient delay Delay in seeking care
Participants had difficulty recalling how long it took for them to notice a problem with their eyesight. Nevertheless, accounts from all four patients who did not regularly attend optometry services included reports of noticeable changes in vision being the stimulus to making a non-routine optometry appointment that led to their glaucoma being detected and immediate referral to hospital eye services. For one participant, it was the work supervisor rather than the participant who first noticed a problem and arranged an optometrist appointment. Healthcare provider delay
Delays in detection and treatment were suggested to have occurred for two main reasons: a failure to detect glaucoma at routine optometry appointments (detection delay) and referral or waiting time delays following detection (service delay).
Detection delay
The main 'trigger' for glaucoma detection in participants who reported attending regular routine optometry appointments was a change in optometrist or a General Practitioner (GP) appointment. Participants' narratives provided compelling accounts of detection delay.
It was detected when the optician looking after me at the time retired and somebody came to take his place and said I think that you have glaucoma… it was on my records for quite a number of years … getting more noticeable. A few participants described reporting symptoms to optometrists during routine appointments that in retrospect they found Patient given letter to take to GP. Patient saw GP the next day Eye clinic phoned patient, 7 days after she saw GP, asking her to attend eye clinic the following week 09 Wore glasses for reading, but had not had an eye test for >10 years Started to notice things looked a different colour through one eye Optometrist referred patient to cataract clinic Saw GP within 3 days of seeing optometrist Patient received letter from hospital with a 'password'. Patient then had to ring hospital to make appointment Attended hospital appointment (at cataract clinic) within 2-3 weeks, but on first visit was told she was in the wrong place and 'quickly' referred her on to her current glaucoma specialist 10 Annual eye checks, cataracts and glaucoma detected at routine visit. Detected by an optometrist that patient had seen on previous appointments
Optometrist referred patient to GP (by letter) GP wrote to patient informing him that an appointment had been made at the hospital. Attended hospital appointment approximately 2 months later 11 Detected at annual eye check With hindsight patient reports pain above the eyes at night (throbbing) for 1 month prior to optometrist appointment, thought it was ear ache Optometrist referred to GP. GP contacted the hospital Patient reports attending ophthalmology clinic the day after GP informed by optometrist. Given letter from optometrist/GP to take with her significant, but which their optometrist did not attribute to glaucoma and which had not led to timely detection. It is worthy of note that the quote above comes from a patient (P06) who reported that her father and grandmother were blind from glaucoma and that in 1992 her optometrist noted an optic disc haemorrhage in her right eye.
I'm the third generation in a row to go blind with this now… I knew glaucoma was a slow advancing disease and I'd been going to the Optometrist since I was 8…therefore in all those years I expected them to have noticed something (P06) Asked when and how her glaucoma was detected she states:
Late on, when 95% of the optic nerve had been destroyed, in both eyes… In 2003, they [optometrist] did the visual fields and they did the photograph of the retina…they said they were referring me to a doctor because the back of my eyes was a bit of a mess…there's been a massive collapse of the visual fields. (P06)
Service delay
Patients' referral pathways from optometry detection to specialised eye service appointment varied by location. In Scotland, participants reported being referred directly to specialist services by their optometrist, while in England, referral from optometry to hospital eye services, as reported by all participants, had to be via their GP.
Two participants (P09 and P04) were initially referred to cataract clinics before being redirected, with minimal delay, to specialist glaucoma services. Waiting times for the initial cataract appointments were reported as 2 weeks and 5 months, respectively. One patient reported having ocular hypotensive therapy initiated at the cataract clinic. For other participants, waiting times between optometry referral and attendance at specialist glaucoma clinics varied from a couple of days to 4 months. However, it is not possible to ascertain from these data whether waiting times reflected the availability of specialist appointments per se (eg, minimum waiting time for all referrals) or the details of the referral (eg, the level of urgency communicated by optometrists or GPs).
So when I went to my GP, which was very quickly after that eye examination within 3 or 4 days. He remarked how he was surprised to see me so quickly and he referred me to the hospital… with the glaucoma specialist but I was marked in a 'no urgency' level so it was actually 15 weeks when I saw somebody. (P06)
Summary of results
The data suggest that late detection of glaucoma can result from delays at the patient level but these findings, although based on a small sample, suggest that delays also occurred at the healthcare provider (system) level both in terms of accuracy of case detection and timely referral.
DISCUSSION
By exploring accounts of the pathways to detection for patients diagnosed with glaucoma at a late stage, this study makes an important contribution to the evidence on late presentation. Other studies have suggested that late presentation is linked to socioeconomic deprivation and frequency of attending for sight tests in community optometry (ie, patient attributes). 4 5 One interpretation of this published evidence is that increased patient awareness and education programmes might encourage earlier detection. Also interventions to break down barriers to access to optometry services at the patient level in areas with high deprivation are being tested. 12 However, this study highlights that it may be appropriate to design interventions to change behaviour not (only) at the patient level but at the healthcare provider levels (healthcare professionals and referral systems). For example, simple decision support tools, alerts and prompts (delivered as leaflets, wall stickers or through computer systems) could be designed to support optometrists' and GPs' decision making.
Technology could help improve detection. The use of automated optic nerve and retinal nerve fibre layer imaging, particularly in eyes with low intraocular pressure where the glaucoma may be missed, could improve timely glaucoma detection. However, the equipment is costly and there is considerable uncertainty about its place in eye services. A large multicentre comparative study of these imaging technologies for the diagnosis of glaucoma is ongoing and will report in 2015. 13 
Implications for policy
Strategies to implement the National Institute of Health and Care Excellence guidelines for glaucoma treatment 14 may raise awareness and knowledge of glaucoma at both the patient and healthcare provider levels. In particular, inclusion of perimetry and optic nerve assessment as part of the optometry test schedule is likely to improve the timeliness and accuracy of referral.
In England, the role of GPs as gatekeepers of care means the referral pathway goes through a generalist (GP) instead of from 'specialist in eyes' (optometry) to 'specialist in eyes' (ophthalmology). While referral refinement systems are in place across the UK with direct referral from optometrists to a specialist eye service, patients' narratives (eg, table 2) indicated there was considerable variation in the post-detection pathway. Consideration should be given to streamlining and standardising this process.
Strengths and limitations of the study
The qualitative design is a strength of this exploratory study as it provided vivid, compelling and rich accounts of patients' experiences and new insights into the reality of diagnostic delay.
The small sample size reflected the exploratory nature of the study. The sample was not selected to be statistically representative and we do not claim that our findings are generalisable. The participants' accounts suggest that they may have either open-angle glaucoma or angle-closure glaucoma but all had advanced glaucoma which could have been avoided by early detection and treatment.
CONCLUSION
The study findings are presented at a time when the main detection pathway issue for glaucoma being addressed in the ophthalmology literature is the significant burden of over-referral of glaucoma suspects to hospital eye services (a large proportion of which are false positives). 15 In contrast, patients such as those included in this study, who reported attending regular eye tests, but who experienced detection delay and first presented at hospital eye services with advanced glaucoma, represent false negatives. Such patients have been denied the opportunity to access early diagnosis and treatment and thus to limit the extent of their visual impairment. We suggest that attempts to address the significant burden of false positives, by refining glaucoma detection and referral by optometrists, 15 must also focus on the issue of false negatives and on reducing missed detection and service delays.
